Daniel Caminada

Daniel Caminada, as an esteemed Executive Board Member at swissbiolabs, plays a pivotal role in shaping the organization’s strategic direction and fostering innovation within the diagnostics ecosystem. Leveraging his extensive background as a molecular biologist with a PhD and over two decades of management experience in the Life Science and Technology industries, Daniel brings a unique blend of scientific expertise and business acumen to the table. His current role involves spearheading initiatives that support the foundation and location of cutting-edge companies in the diagnostics field, emphasizing the translation of groundbreaking scientific ideas into viable, market-ready enterprises.

At swissbiolabs, Daniel is deeply engaged in identifying emerging market opportunities within genomics, proteomics, and laboratory automation, ensuring that scientific advancements are seamlessly integrated into entrepreneurial ventures. His expertise in R&D, product management, and technology transfer enables him to oversee projects that accelerate product development and facilitate successful product launches. Daniel’s strategic vision is complemented by his ability to foster collaborations among scientists, entrepreneurs, economic experts, and investors—an approach that aligns with swissbiolabs’ mission to promote knowledge transfer and entrepreneurship in life sciences.

Through his leadership, swissbiolabs continues to serve as a vital nexus for innovation, supporting startups and established companies alike in navigating the complex landscape of diagnostics technology. Daniel’s passion for making things happen and his knack for converting scientific ideas into valuable business opportunities make him a driving force behind the organization’s success in advancing healthcare solutions and strengthening Switzerland’s position as a hub for life sciences innovation.